Daprodustat in renal anaemia: changing the response to cellular hypoxia, but is it a game changer?

Cardiovasc Res. 2022 Jun 29;118(8):e54-e56. doi: 10.1093/cvr/cvac067.

Authors

Michael K Sullivan¹, Patrick B Mark¹

Affiliation

¹ BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, 126 University Place, Glasgow G12 8TA, UK.

PMID: 35639861
DOI: 10.1093/cvr/cvac067

No abstract available

Keywords: Anaemia; Chronic kidney failure; Daprodustat; Hypoxia-inducible factor-proline dioxygenases.

MeSH terms

Anemia* / diagnosis
Anemia* / drug therapy
Barbiturates
Cell Hypoxia / physiology
Glycine / analogs & derivatives
Humans
Hypoxia / drug therapy
Renal Insufficiency, Chronic*

Substances

Barbiturates
GSK1278863
Glycine